CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported by the expansion to 48 ...

Canaccord raised the firm’s price target on CVRx (CVRX) to $23 from $22 and keeps a Buy rating on the shares. The firm said the reported better ...

TORONTO , Feb. 4, 2025 /CNW/ - Canaccord Genuity Group Inc. (Canaccord Genuity Group, the Company) (TSX: CF) today announced its financial results for the third fiscal quarter and nine months ended ...

Ben Krasinski; Director, Investor Relations; Premier Inc. Michael Alkire; President, Chief Executive Officer, Director; Premier Inc. Glenn Coleman; Chief Financial O ...

Presentation Operator Good, everyone, and welcome to the Energy's 4th-Quarter 2024 Financial Results Conference Call. All ...